Abbott shines as its bring continuous glucose monitoring solutions closer to Indian homes with 1mg

31 Jul 2020 Evaluate

Abbott India is currently trading at Rs. 15400.00, up by 502.55 points or 3.37% from its previous closing of Rs. 14897.45 on the BSE.

The scrip opened at Rs. 14801.10 and has touched a high and low of Rs. 15700.00 and Rs. 14801.10 respectively. So far 1850 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 18569.00 on 04-May-2020 and a 52 week low of Rs. 8,317.50 on 1-Aug-2019.

Last one week high and low of the scrip stood at Rs. 15700.00 and Rs. 14749.80 respectively. The current market cap of the company is Rs. 32589.20 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 7.32% and 17.69% respectively.

Abbott and leading online pharmacy and healthcare platform, 1mg have entered into collaboration to make Abbott’s continuous glucose monitoring products available online, including its professional flash glucose monitoring system, FreeStyle Libre Pro. Patients in India can upload a healthcare practitioner’s prescription and purchase the product online on 1mg. An on-site phlebotomy service will be provided at the patient’s home with a phlebotomist helping the patient administer the sensor and take readings of the data after 14 days, enabling them to start using the device.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

 

Abbott India Share Price

27959.55 -268.55 (-0.95%)
12-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1794.30
Dr. Reddys Lab 1279.65
Cipla 1517.20
Zydus Lifesciences 929.05
Lupin 2114.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×